Month: December 2022
-
December 6th, 2022: Ratio Therapeutics Appoints Reed Malleck as Chief Financial Officer
BOSTON, December 6, 2022 – Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers, today announced the appointment of Reed Malleck as the company’s Chief Financial Officer (CFO).